<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-AFG-Z-UNDP</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Combined grant to support HIV/AIDS, Tuberculosis &amp; Malaria programs and Health Systems in Afghanistan</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Afghanistan - Multicomponent - United Nations Development Programme - UNDP Afghanistan.  This program has the following goals: The goal of the NSP IV is to halt new HIV, STI &amp; Hepatitis infections and improve the health and quality of life of people living with and affected by HIV, STIs, and Hepatitis in Afghanistan over the next five years..  To reduce TB deaths by 75% by the end of 2025 compared to 2015.  To ensure that Afghanistan is on track to eliminate malaria by 2030 &#x2013; contributing towards country development and the Sustainable Development Goals.  To decrease TB incidence rate by 20% by 2024 (to reach 50% reduction in incidence rate compared to 2015) in order to be aligned with End TB Strategy.  To strengthen the health system to reduce mortality and morbidity associated with ATM and RMNCH. The objectives of this program are: To focus strategically on prevention services for HIV and other infections for key populations (PWID, MHRB, WHRB and prisoners).  To increase the case notification of all TB cases at least 12% annually until 2023 and maintain full coverage thereafter, and to sustain treatment success rate, at least, 90% by 2025.  Reducing the reported malaria incidence by 73% at the national level compared with 2016.  To increase the coverage and quality of opiod substitution therapy for people who inject drugs by 2023.  To detect and treat at least 80% of estimated MDR-TB cases by 2025.  Interrupting indigenous transmission of malaria in 23 Provinces (Badghis, Baghlan, Farah, Ghor, Hirat, Jawzjan, Kabul, Kunduz, Nimroz, Parwan, Samangan, Balkh, Bamyan, Dykundi, Kapisa, Panjsher, Sar-e-Pul, Takhar, Urozgan, Badakhshan, Faryab, Logar and Zabul) by 2022.  To increase the coverage and quality of antiretroviral therapy services for people living with HIV by 2023.  To detect and treat at least 50% of the estimated latent TB cases as the accumulation by 2025.  Preventing the re-establishment of local malaria transmission due to importation in all areas where it has been eliminated.  To strengthen capacity and systems to generate strategic information on HIV, STIs and Hepatitis through biological and behavior surveillance, surveys and research for evidence-based response to the HIV, STIs and Hepatitis epidemic.  To increase access of women and children to health care services for RMNCAH, HIV, TB and malaria, reduced stigma and discrimination and promotion of health lifestyles in the community and in health facilities in underserved areas.  To improve the enabling environment to address enhanced coordination, human rights, positive legal environment, strengthened community systems, increased domestic funding, reduced stigma and discrimination, to address the needs and rights of key populations affected by HIV, STIs and Hepatitis.  To maintain and improve the quality of the National Laboratory Network.  To improve institutional capacity of Civil Society Organizations and private sector for effective implementation of TB, Malaria and HIV.  To ensure high quality pharmaceuticals and health commodities by strengthening the supply chain, procurement, management, Quality Assurance and regulatory systems.  To improve the data quality of the HMIS and strengthen the utilization of data for decision-making at all levels</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Afghanistan</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Afghanistan</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <participating-org role="3" type="40">
   <narrative xml:lang="EN">United Nations Development Programme</narrative>
  </participating-org>
  <participating-org role="4" type="40">
   <narrative xml:lang="EN">United Nations Development Programme</narrative>
  </participating-org>
  <other-identifier ref="02dfd93c-c1fc-43d9-a927-9653eaa35c3a" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="AFG-Z-UNDP" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-09-22" type="1"></activity-date>
  <activity-date iso-date="2021-09-22" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Enkhjin BAVUU</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>enkhjin.bavuu@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Enkhjin BAVUU</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>enkhjin.bavuu@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="AF" percentage="100">
   <narrative xml:lang="EN">Afghanistan</narrative>
  </recipient-country>
  <sector code="12220" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Multicomponent</narrative>
  </sector>
  <sector code="MULTICOMPONENT" percentage="100" vocabulary="99" vocabulary-uri="http://data-service.theglobalfund.org//v2.1/odata/components">
   <narrative xml:lang="EN">Multicomponent</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.62" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="19.03" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="7.51" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="14.11" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="4.33" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="19" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="14.83" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="1.03" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="0.91" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="1.28" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="0.19" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="7.21" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="9.94" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-10-01">34315716</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-10-01">10313289</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-10-01">6264564</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-10-01">9322769</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-10-01">3032198</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-10-01">6363169</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-10-01">3558696</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-10-01">2990042</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-10-01">2932147</value>
  </budget>
  <capital-spend percentage="7.51"></capital-spend>
  <transaction ref="3d3032b8-ad70-4792-b02a-8685e93948a2">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-12-20"></transaction-date>
   <value currency="USD" value-date="2021-12-20">54192116.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to AFG-Z-UNDP.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ebf8ce55-19be-4c78-9d58-e95e772b9492">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-13"></transaction-date>
   <value currency="USD" value-date="2022-01-13">-19876409.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to AFG-Z-UNDP.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6f09b4db-1661-4266-9059-22abb2afbbcf">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-13"></transaction-date>
   <value currency="USD" value-date="2022-01-13">14893470</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to AFG-Z-UNDP.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b15ef1c9-dd89-4e1c-8cd7-861de9a0dc91">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-06"></transaction-date>
   <value currency="USD" value-date="2022-01-06">34315707</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to AFG-Z-UNDP.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for AFG-Z-UNDP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">KP Other1: Percentage of WHRB reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 4282 Denominator: 7261 Percentage: 58.97</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4282</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 10430 Denominator: 5402 Percentage: 193.08</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">SD-Other1: Number of people receiving services through Family Health Houses (FHHs)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 105736 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1114077 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Target / Risk population group" value="Other population group"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1114077</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 11154 Denominator: 52770 Percentage: 21.14</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 112 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Transgender"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 0 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1044 Denominator: 7794 Percentage: 13.39</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Male 20-24"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 114</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Female 15-19"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 13</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Male 15-24"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 146</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Duration of treatment" value="Newly initiating ART"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 192 Denominator: 7794 Percentage: 2.46</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Female 15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 294 Denominator: 2188 Percentage: 13.44</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Female 20-24"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 31</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Male 15-19"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 32</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Female 15-24"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 44</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 60 Denominator: 354 Percentage: 16.95</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 60 Denominator: 354 Percentage: 16.95</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender | Age" value="Male 15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 690 Denominator: 5253 Percentage: 13.14</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 984 Denominator: 7440 Percentage: 13.23</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 984 Denominator: 7440 Percentage: 13.23</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">LAB-Other3: Percentage of provincial laboratories showing adequate performance in external quality assurance among the total number of laboratories that undertake bacteriology services during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 12 Denominator: 13 Percentage: 92.31</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of malaria cases (presumed and confirmed) that received first line antimalarial treatment at public sector health facilities</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 120650 Denominator: 123204 Percentage: 97.93</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 29571 Denominator: 30278 Percentage: 97.66</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 91079 Denominator: 92926 Percentage: 98.01</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in prisons or other closed settings that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14261</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 14264 Denominator: 21182 Percentage: 67.34</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HTS Other1: Percentage of WHRB hat have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="25+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1503</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2492</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 2495 Denominator: 7261 Percentage: 34.36</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2495</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;25"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 992</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in prisons and other closed settings reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 20082 Denominator: 21182 Percentage: 94.81</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 208</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 6732</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 8265 Denominator: 17690 Percentage: 46.72</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14584</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 15034</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 19395</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2100</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 25051</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 28</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 44082 Denominator: 48420 Percentage: 91.04</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 8469</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 221993 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Target / Risk population group" value="Pregnant women"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 221993</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 103863 Denominator: 103870 Percentage: 99.99</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 146390 Denominator: 146441 Percentage: 99.97</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 250253 Denominator: 250311 Percentage: 99.98</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of testing" value="Rapid diagnostic test"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 250253</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in contact with TB patients who began preventive therapy</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 24701 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26728</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 2750 Denominator: 3012 Percentage: 91.30</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">SD-Other2: Number of people receiving services through Public-Private Partnerships (PPPs)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 29892 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="25+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2845</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;25"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3074</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5912</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 5919 Denominator: 5402 Percentage: 109.57</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 351 Denominator: 471 Percentage: 74.52</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 168</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 314</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 402</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 482 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of malaria cases (presumed and confirmed) that received first line antimalarial treatment at private sector sites</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 4036 Denominator: 4226 Percentage: 95.50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 416</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Target / Risk population group" value="Other population group"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5147</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 5563 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of malaria cases (presumed and confirmed) that received first line antimalarial treatment in the community</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 17648 Denominator: 18880 Percentage: 93.47</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26656 Denominator: 28583 Percentage: 93.26</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 44304 Denominator: 47463 Percentage: 93.34</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 11474</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 21656</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22565</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26216</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 29873</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 30771</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 40964</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 52438 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 127</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="25+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4331</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4786</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4911</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 4916 Denominator: 17690 Percentage: 27.79</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;25"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 585</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">LAB-Other2: Percentage of regional laboratories showing adequate performance in external quality assurance  among the total number of laboratories that undertake available services during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 6 Denominator: 6 Percentage: 100.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 16621 Denominator: 16621 Percentage: 100.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of testing" value="Rapid diagnostic test"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 16621</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7113 Denominator: 7113 Percentage: 100.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9508 Denominator: 9508 Percentage: 100.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Type of testing" value="Rapid diagnostic test"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 184631</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 213667 Denominator: 213777 Percentage: 99.95</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 532018 Denominator: 532884 Percentage: 99.84</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of testing" value="Microscopy"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 561054</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 745685 Denominator: 746661 Percentage: 99.87</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 7654 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; private/non-governmental facilities</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 7697 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">LAB-Other1: Laboratory functionality index</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 81.80</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for AFG-Z-UNDP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 116 Denominator: 146 Percentage: 79.45</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 203 Denominator: 271 Percentage: 74.91</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 319 Denominator: 417 Percentage: 76.50</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 125 Denominator: 198 Percentage: 63.13</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 65.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 66.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 67.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">National aggregate HMIS fully deployed and functional: Percentage of HMIS components in place (HIS deployment, completeness, timeliness, and integration of aggregate disease reporting for HIV, TB and malaria indicators)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 3 Denominator: 4 Percentage: 75.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3 Denominator: 4 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3 Denominator: 4 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3 Denominator: 4 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 44082 Denominator: 48420 Percentage: 91.04</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 91.04</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 91.04</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 91.04</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 52438 Denominator: 71657 Percentage: 69.17</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 92.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 100.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of population that slept under an insecticide-treated net the previous night</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Percentage: 14.60</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of pregnant women who slept under an insecticide-treated net the previous night</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Percentage: 14.90</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of children under five years old who slept under an insecticide-treated net the previous night</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Percentage: 16.80</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HIV O-Other1:  Percentage of MHRB who report the use of an HIV protective measure at last sexual intercourse</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 17.40</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Percentage: 2.90</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reporting condom use at last sex</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 23.40</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HIV O-Other2: Percentage of WHRB reporting the use of an HIV protective measure with their most recent sexual intercourse</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 51.50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reporting the use of sterile injecting equipment the last time they injected</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 78.20</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for AFG-Z-UNDP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Inpatient malaria deaths per year: rate per 100,000 persons per year</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Species" value="Other species"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 123148</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Species" value="P. Vivax"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 170746</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Species" value="P. Falciparum"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2701</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Species" value="Mixed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 412</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 5.51</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 50711</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2.8</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2.47</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2.14</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 29</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 21</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 17</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Reported malaria cases (presumed and confirmed)</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Malaria case definition" value="Presumptive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1034</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 124065</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Malaria case definition" value="Confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 173859</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 174893</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 50828</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 105669</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 95205</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 84362</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Malaria test positivity rate</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Type of testing" value="Rapid diagnostic test"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 102470</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 173859 Denominator: 1012559 Percentage: 17.17</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Species" value="P. Falciparum"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3113 Denominator: 1012559 Percentage: 0.31</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of testing" value="Microscopy"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 71389</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 104532 Denominator: 1287050 Percentage: 8.12</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 94068 Denominator: 1313177 Percentage: 7.16</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 83225 Denominator: 1341279 Percentage: 6.20</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HIV I Other2 Percentage of WHRB who are living with HIV</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 0.30</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HIV I-Other1 Percentage of MHRB who are living with HIV</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 0.40</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of other vulnerable populations (specify) who are living with HIV</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 0.70</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs who are living with HIV</narrative>
    </title>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Percentage: 4.40</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 4.90</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.90</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.90</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.90</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
